torsdag den 25 april

Stora bolag och nordisk spets

Ellinor Beckett
Stockholmsbörsen
(), idag
-
-

Xbrane Biopharma
Xbrane Biopharma: A bright future (Redeye)

2021-08-02 10:20
Redeye raises its valuation on Xbrane following the positive outcome of its phase III study Xplore. Development is the core of Xbrane’s strategy, and the company’s biosimilar development approach has now received validation.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Xbrane Biopharma - I dag

{point.key}

Senaste nytt

Visa alla telegram

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex
Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor
Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor
Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror
Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -